GraphPad Prism vs Excel for qPCR Statistical Analysis: Which One Should You Actually Use?

If you're running unpaired t-tests on ΔCt values to compare two treatment groups, Excel can do that fine. If you need to run a two-way ANOVA across multiple genes and timepoints, produce publication-quality volcano or bar plots, and handle post-hoc corrections without building everything from scratch — Prism is worth the license fee. That's the short version.

The longer version is that most qPCR analysis errors don't come from choosing the wrong software. They come from running statistics on the wrong values (fold changes instead of ΔCt), forgetting to check normality assumptions on small sample sizes, or plotting individual replicate wells as though they're biological replicates. Both Excel and Prism will happily let you do all of these things incorrectly. The tool matters less than understanding what it's doing to your data.

What Each Tool Actually Does Well

Excel is where most of us start, and for the ΔΔCt calculation itself it's perfectly adequate. You set up columns for your raw Ct values, subtract your reference gene (GAPDH, ACTB, whatever you've validated), subtract your control group mean to get ΔΔCt, and raise 2 to the negative power to get fold change. This is a spreadsheet task, and Excel handles spreadsheet tasks. You can calculate means, standard deviations, SEMs, and even run a t-test using =T.TEST() or the Data Analysis ToolPak. For a simple two-group comparison — treated vs. untreated, one gene, one reference — this workflow is fine.

Where Excel starts to hurt:

• No built-in post-hoc tests. If you have three or more groups, you need ANOVA followed by Tukey's, Dunnett's, or Šídák's correction. Excel's ToolPak gives you one-way ANOVA but no post-hoc tests. You end up running multiple t-tests without correction, which inflates your false positive rate. I've reviewed papers where people compared five treatment groups with ten pairwise t-tests in Excel. Don't be that person.
• Plotting is painful. You can make bar graphs in Excel. You cannot easily make them look like something a journal will accept without 30 minutes of reformatting axis labels, error bars, and significance brackets. Every. Single. Time.
• No normality testing. With qPCR biological replicates (often n = 3–6), you're working with small samples. Excel doesn't offer Shapiro-Wilk or any other normality test. You're assuming your ΔCt values are normally distributed because you have no easy way to check.

Prism handles all of the above out of the box. You paste your ΔCt values into a grouped data table, choose your analysis (unpaired t-test, one-way ANOVA, two-way ANOVA), and Prism runs the appropriate post-hoc test, flags whether your data pass normality checks (it runs Shapiro-Wilk and offers the option for Brown-Forsythe or Welch ANOVA if variances are unequal), and produces a graph you can drag into Illustrator or drop straight into a manuscript. The statistical output is organized, the multiplicity-adjusted p-values are clearly labeled, and you can switch between parametric and nonparametric tests with a click.

Prism also handles things like plotting individual data points over bar graphs (which reviewers increasingly expect), asymmetric error bars on fold-change plots, and automatic significance brackets. These sound minor until you've spent an hour trying to add significance stars to an Excel chart.

Run Your Statistics on ΔCt, Not Fold Change

This is the single most common statistical mistake in qPCR analysis, and it happens equally in both Excel and Prism. The ΔΔCt fold change (2^−ΔΔCt) is a ratio on a log-transformed scale. It's not normally distributed — it's right-skewed by definition, since downregulation compresses between 0 and 1 while upregulation extends to infinity. Running a t-test or ANOVA on fold-change values violates the normality assumption of these tests.

The correct approach: run your statistics on ΔCt values (Ct_GOI − Ct_REF for each biological replicate). These are approximately normally distributed because they're differences of roughly normal variables. Calculate your p-values from the ΔCt comparison, then convert to fold change for plotting and reporting. This is the approach described in the original Livak and Schmittgen paper (Livak & Schmittgen, 2001) and is standard practice.

In Excel, this means your t-test formula references the ΔCt columns, not the fold-change column. In Prism, you set up your ΔCt values in the data table, run the analysis there, and then create a separate summary table with fold-change values for your figure. Prism doesn't enforce this — you can absolutely paste fold changes into Prism and run a t-test on them and it won't stop you. You have to know the right input.

If your amplification efficiencies differ meaningfully between target and reference (outside the 90–110% range, or differing by more than 5% between genes), you should be using the Pfaffl method (Pfaffl, 2001) instead of the Livak ΔΔCt approach. In that case, your ratio calculation incorporates efficiency values, and the statistics get slightly more involved — you'd want to use a randomization or bootstrapping approach like those implemented in REST (Pfaffl et al., 2002). Neither Excel nor Prism handles the Pfaffl model natively.

The Biological Replicate Problem

Both tools will analyze whatever you throw at them, including data where you've treated technical replicate wells as independent data points. This is worth flagging because it's rampant.

If you ran three biological replicates (three independent RNA extractions from three separate flasks, plates, or animals) and plated each in triplicate, you have n = 3, not n = 9. The triplicate wells should be averaged to give you one Ct value per biological replicate, and the standard deviation of those triplicates should be <0.5 Ct (ideally <0.3). If one of your triplicates is an outlier (e.g., Ct values of 22.1, 22.3, and 24.8), investigate the cause — likely a pipetting error — and consider excluding it. The remaining two wells still give you a usable average for that biological replicate.

In Excel, this means your t-test compares three values against three values. In Prism, same thing — three rows per group. Running stats on nine values per group because you treated each well as independent artificially narrows your confidence intervals and gives you p-values that don't reflect the actual variability in your experiment. Reviewers who know qPCR will catch this. More importantly, your conclusions may not hold up if the real n is 3.

When Prism Isn't Worth It

Prism licenses cost around $150–250/year for academic users. If your qPCR analysis consistently involves:

• One gene of interest, one reference gene, two groups (treated vs. control)
• Three to six biological replicates
• The Livak ΔΔCt method with validated efficiencies

...then Excel or Google Sheets genuinely does the job. A well-built template with the ΔCt calculation, a =T.TEST() call, and a simple bar chart covers it. I'd still recommend calculating a 95% confidence interval on the ΔΔCt and converting the bounds to fold change to get asymmetric error bars on the fold-change plot — this is doable in Excel, just tedious the first time.

Prism starts paying for itself when:

• You have three or more experimental groups and need proper ANOVA with post-hoc corrections.
• You're comparing multiple genes across conditions and need to manage and visualize that data without drowning in tabs.
• You need two-way ANOVA (e.g., gene × treatment, or treatment × timepoint).
• You want nonparametric alternatives (Mann-Whitney, Kruskal-Wallis) because your sample size is too small to assume normality.
• You need to produce figures for publication without routing through a separate graphing tool.

The Option Neither Tool Covers Well

Neither Excel nor Prism automates the upstream qPCR-specific quality checks: flagging NTC amplification, checking melt curve consistency, validating reference gene stability across your experimental conditions (the kind of analysis geNorm or NormFinder does — Vandesompele et al., 2002; Andersen et al., 2004), or calculating amplification efficiency from a standard curve with automatic outlier detection. They both assume you've already processed your raw Ct data correctly and are ready for statistics.

That upstream gap — from raw instrument export to analysis-ready ΔCt values — is where most errors actually enter the pipeline. You export a CSV from your QuantStudio or CFX96, manually average triplicates, maybe miss that one of your NTC wells hit a Ct of 36, and carry those values forward into your stats. By the time you're in Prism, the damage is done.

This is the problem VoilaPCR is built to solve. Upload your instrument file, and it handles replicate averaging, outlier flagging, NTC checking, efficiency validation, and ΔΔCt calculation automatically — then gives you analysis-ready values you can drop into Prism, or just use the built-in stats and figures directly. It won't replace Prism for complex multi-factor experimental designs, but for the standard qPCR workflow, it catches the mistakes that neither Excel nor Prism is designed to look for.